Status:
COMPLETED
Clomid in Men With Low Testosterone With and Without Prior Treatment
Lead Sponsor:
Phoenix VA Health Care System
Conditions:
Hypogonadism, Male
Eligibility:
MALE
30-70 years
Phase:
PHASE2
Brief Summary
This study aims to explore whether men with low testosterone levels, due to altered brain regulation of male hormone function, who have been previously treated with testosterone, respond as well as me...
Detailed Description
Clomiphene, an oral FDA-approved agent for female infertility has been shown to normalize testosterone levels in men with hypogonadotropic hypogonadism. It appears to be safe and well tolerated. This ...
Eligibility Criteria
Inclusion
- Patient or eligible for care at Phoenix VA Health Care System
- Male ages 30-70 years
- testosterone level below 250 ng/dl before treatment
- able to provide informed written consent
Exclusion
- evidence of pituitary tumor \>1mm by MRI or CAT scan
- chronic illness (renal, cardiac, liver failure)
- Prostate specific antigen (PSA) \>4.0 ng/ml
- history of prostate, breast, or testicular cancer
- eye disease compromising vision (e.g. cataracts)
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01904734
Start Date
October 1 2012
End Date
October 31 2018
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix VA Health Care System
Phoenix, Arizona, United States, 85012